University of British Columbia, Vancouver, BC, Canada.
Centre for Health Evaluation and Outcome Sciences, Vancouver, Canada.
Med Decis Making. 2021 Oct;41(7):954-959. doi: 10.1177/0272989X211011120. Epub 2021 May 8.
In 2014, a systematic review found large gaps in the quality of reporting of measures used in 86 published trials evaluating the effectiveness of patient decision aids (PtDAs). The purpose of this study was to update that review.
We examined measures of decision making used in 49 randomized controlled trials included in the 2014 and 2017 Cochrane Collaboration systematic review of PtDAs. Data on development of the measures, reliability, validity, responsiveness, precision, interpretability, feasibility, and acceptability were independently abstracted by 2 paired reviewers.
Information from 273 measures was abstracted, and 109 of these covered the core domains of decision processes ( = 55) and decision quality including informed choice/knowledge ( = 48) and values-choice concordance ( = 12). Very few studies reported data on the performance and clinical sensibility of measures, with reliability (23%) and validity (6%) being the most common. Studies using new measures were less likely to include information about their psychometric performance compared with previously published measures.
The review was limited to reporting of measures in studies included in the Cochrane review and did not consult prior publications.
There continues to be very little reported about the development or performance of measures used to evaluate the effectiveness of PtDAs in published trials. Minimum reporting standards have been published, and efforts to require investigators to use them are needed.
2014 年,一项系统评价发现,在评估患者决策辅助工具(PtDAs)有效性的 86 项已发表试验中,所使用的测量方法的报告质量存在很大差距。本研究旨在更新该评价。
我们检查了 2014 年和 2017 年 Cochrane 协作组对 PtDAs 的系统评价中纳入的 49 项随机对照试验中使用的决策测量方法。由 2 对评审员独立提取关于测量方法的制定、可靠性、有效性、反应度、精密度、可解读性、可行性和可接受性的数据。
共提取了 273 个测量方法的信息,其中 109 个涵盖了决策过程的核心领域( = 55)和决策质量,包括知情选择/知识( = 48)和价值观-选择一致性( = 12)。很少有研究报告测量方法的性能和临床敏感性数据,可靠性(23%)和有效性(6%)是最常见的。与先前发表的测量方法相比,使用新测量方法的研究不太可能包括其心理测量性能的信息。
该综述仅限于 Cochrane 评价中纳入研究的测量方法报告,并未查阅先前的出版物。
在已发表的试验中,用于评估 PtDAs 有效性的测量方法的开发或性能报告仍然非常少。已经发布了最低报告标准,需要努力要求研究人员使用这些标准。